Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.427 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.302NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.222NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.467NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.74 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.621.1 (Mu)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.16.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.9.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XEBNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-14812.6US
B.1.263NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.180NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.464NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.234NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.231NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.291NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.349NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.314NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.132NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used